Hologic announces offering of $350 Million of Senior Notes due 2025

Hologic announces offering of $350 Million of Senior Notes due 2025
share Share
- Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes -


Hologic, Inc. (NASDAQ: HOLX) has announced that it has launched, subject to market and other conditions, a private offering of $350 million aggregate principal amount of senior notes due 2025.  Hologic intends to use the proceeds of the offering and available cash, including funds from its new five-year secured credit agreement, to retire the Company's remaining convertible notes, including through repurchases or redemptions, when they become callable in December of 2017 and March of 2018.


The 2025 notes will not be registered under the Securities Act of 1933, as amended, or any state securities laws.  Unless so registered, the securities may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities law.  The 2025 notes are being offered only to qualified institutional buyers in reliance on Rule 144A under the Securities Act, and outside the United States in accordance with Regulation S under the Securities Act.


This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction where the offer, solicitation or sale is not permitted. 


Source & Image Credit: Hologic


Find More About Hologic

Published on : Wed, 4 Oct 2017



Related Articles
Hologic enters into amended and restated five-year secured credit agreement

- Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt... Read more

Panther Fusion® Flu A/B/RSV Assay Now FDA Cleared on Hologic's New Panther Fusion® System

- New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory... Read more

Hologic Receives CE Mark to Market SculpSure® for Non-Invasive Body Contouring (Lipolysis) of the Submental Area (Under the Chin)

Patients in Clinical Studies Report 100% Satisfaction Hologic, Inc. (Nasdaq: HOLX) has announced that it has received... Read more

Hologic,Senior Notes,financials Hologic announces offering of $350 Million of Senior Notes due 2025

No comment


Please login to leave a comment...

Highlighted Products